151 related articles for article (PubMed ID: 9827222)
21. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
22. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
[TBL] [Abstract][Full Text] [Related]
23. An unusual cutaneous T cell lymphoma presenting as leonine facies.
Vocks E; Hertenberger B; Worret WI; Kaudewitz P; Fellbaum C; Ring J
Eur J Dermatol; 2000 Jun; 10(4):309-12. PubMed ID: 10846262
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
25. Classification of primary cutaneous T-cell lymphomas.
Willemze R; Beljaards RC; Meijer CJ
Histopathology; 1994 May; 24(5):405-15. PubMed ID: 8088712
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous lymphomas: a review with current treatment options.
Querfeld C; Guitart J; Kuzel TM; Rosen ST
Blood Rev; 2003 Sep; 17(3):131-42. PubMed ID: 12818223
[TBL] [Abstract][Full Text] [Related]
27. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
29. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
30. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
31. Rationale of a new classification for the group of primary cutaneous lymphomas.
Willemze R; Meijer CJ
Semin Cutan Med Surg; 2000 Jun; 19(2):71-7. PubMed ID: 10892707
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients.
Fink-Puches R; Zenahlik P; Bäck B; Smolle J; Kerl H; Cerroni L
Blood; 2002 Feb; 99(3):800-5. PubMed ID: 11806979
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
34. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in cutaneous lymphomas.
Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
[TBL] [Abstract][Full Text] [Related]
36. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
37. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer.
Willemze R; Meijer CJ
Am J Dermatopathol; 1999 Jun; 21(3):265-73. PubMed ID: 10380050
[TBL] [Abstract][Full Text] [Related]
38. T-cell primary cutaneous lymphomas. A clinicopathological and immunohistochemical study.
Caruntu ID; Mardari V; Radulescu D; Chirana A; Cozma L; Taranu T; Dobrescu G
Pol J Pathol; 2007; 58(4):259-65. PubMed ID: 18459460
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous lymphomas other than mycosis fungoides.
Joly P; Thomine E; Lauret P
Semin Dermatol; 1994 Sep; 13(3):172-9. PubMed ID: 7986685
[No Abstract] [Full Text] [Related]
40. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
Tancrède-Bohin E; Ionescu MA; de La Salmonière P; Dupuy A; Rivet J; Rybojad M; Dubertret L; Bachelez H; Lebbé C; Morel P
Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
